A mass spectrometric strategy for profiling glycoproteinoses, Pompe disease, and sialic acid storage diseases

Proteomics - Clinical Applications

Volumn 2, Issue 4, 2008, Pages 528-542

  Faid, Valegh ^a   Michalski, Jean Claude ^a   Morelle, Willy ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

Author keywords

Glycoproteinoses; I cell disease; Oligosacchariduria; Pompe disease; Sialic acid storage diseases

Indexed keywords

CARBON; GLYCAN; GLYCOPEPTIDE; GLYCOPROTEIN; GLYCOSIDASE; OLIGOSACCHARIDE; SIALIC ACID;

ARTICLE; ASPARTYLGLYCOSAMINURIA; CONTROLLED STUDY; FUCOSIDOSIS; GAS CHROMATOGRAPHY; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; INBORN ERROR OF METABOLISM; MANNOSIDOSIS; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MORQUIO SYNDROME; MUCOLIPIDOSIS TYPE 2; NEWBORN SCREENING; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PURIFICATION; PROTEIN URINE LEVEL; PROTEINOSIS; SANDHOFF DISEASE; SIALIC ACID STORAGE DISEASE; SIALIDOSIS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

EID: 42449136258     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780097     Document Type: Article

References (69)

1. Wraith, J. E., Lysosomal disorders. Semin. Neonatol. 2002, 1, 75-83.
2. Michalski, J. C., Normal and pathological catabolism of glycoproteins. in: Montreuil, J., Vliegenthart, J. F. G., Schachter, H. (Eds.) Glycoproteins and Disease. Elsevier Science BV, Amsterdam 1996, pp. 55-97.
3. Thomas, G. H., Disorders of glycoprotein degradation: α-mannosidosis, β-mannosidosis, fucosidosis, and sialidosis. in: Scriver, S. R., Beaudet, A. L., Sly, W. S., Valle, D. (Eds.) The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, London 2001, pp. 3507-3533.
4. Tondeur, M., Vamos-Hurwitz, E., Mockel-Pohl, S., Dereumess, J. P. et al., Clinical, biochemical, and ultrastructural studies in a case of chondrodystrophy presenting the I-cell phenotype in tissue culture. J. Pediatr. 1971, 79, 366-785.
5. Kumar, T. S., Scott, J. X., Raghupathy, P., Moses, P. D., Mucolipidosis II (I-cell disease). J. Postgrad. Med. 2005, 51, 232-233.
6. Cori, G. T., Biochemical aspects of glycogen deposition disease. Bibl. Paediatr. 1958, 14, 344-358.
7. Hallgren, P., Hansson, G., Henriksson, K. G., Hager, A. et al., Increased excretion of a glucose-containing tetrasaccharide in the urine of a patient with glycogen storage disease type II (Pompe's disease). Eur. J. Clin. Invest. 1974, 4, 429-433.
8. Hancock, L. W., Thaler, M. M., Horwitz, A. L., Dawson, G., Generalized N-acetylneuraminic acid storage disease: Quantitation and identification of the monosaccharide accumulating in brain and other tissues. J. Neurochem. 1982, 38, 803-809.
9. Tondeur, M., Libert, J., Vamos, E., van Hoof, F. et al., Thomas, Infantile form of sialic acid storage disorder: Clinical, ultrastructural, and biochemical studies in two siblings. Eur. J. Pediatr. 1982, 139, 142-147.
10. Aula, P., Autio, S., Raivio, K. O., Rapola, J. et al., "Salla disease" A new lysosomal storage disorder. Arch. Neurol. 1979, 36, 88-94.
11. Fontaine, G., Gaudier, B., Biserte, G., Montreuil, J. et al., Permanent urinary elimination of free sialic acid in a 3-year-old child affected with diverse clinical disorders. Pediatrie 1967, 22, 705-709.
12. Gopaul, K. P., Crook, M. A., The inborn errors of sialic acid metabolism and their laboratory investigation. Clin. Lab. 2006, 52, 155-169.
13. Aula, N., Aula, P., Prenatal diagnosis of free sialic acid storage disorders (SASD). Prenat. Diagn. 2006, 26, 655-658.
14. Warren, L., The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 1959, 234, 1971-1975.
15. Paschke, E., Gruber, W., Ring, E., Sperl, W., Storage material from urine and tissues in the nephropathic phenotype of infantile sialic acid storage disease. J. Inherit. Metab. Dis. 1992, 15, 47-56.
16. Stankovics, J., Molnar, D., Burus, I., Pinter, Z., Infantile sialic acid storage disease diagnosed by gas chromatography-mass spectroscopy analyses of urine sample. J. Inherit. Metab. Dis. 1997, 20, 728-729.
17. Meikle, P. J., Fietz, M. J., Hopwood, J. J., Diagnosis of lysosomal storage disorders: Current techniques and future directions. Expert Rev. Mol. Diagn. 2004, 4, 677-691.
18. Kin, N. M., Wolfe, L. S., High-performance liquid chromatographic analysis of oligosaccharides and glycopeptides accumulating in lysosomal storage disorders. Anal. Biochem. 1980, 102, 213-219.
19. Hommes, F. A., Varghese, M., High-performance liquid chromatography of urinary oligosaccharides in the diagnosis of glycoprotein degradation disorders. Clin. Chim. Acta 1991, 203, 211-24.
20. Peelen, G. O. H., de Jong, J. G. N., Wevers, R. A., HPLC analysis of oligosaccharides in urine from oligosaccharidosis patient. Clin. Chem. 1994, 40, 914-921.
21. Starr, C. M., Klock, J. C., Skop, E., Masada, I., Giudici, T., Fluorophore assisted electrophoresis of urinary carbohydrates for the identification of patients with oligosaccharidosis and mucopolysaccharidosis-type lysosomal storage diseases. Glycosylation Dis. 1994, 1, 165-170.
22. Roschinger, W., Olgemoller, B., Fingerhut, R., Liebl, B., Roscher, A. A., Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases. Eur. J. Pediatr. 2003, 1, 67-76.
23. Want, E. J., Cravatt, B. F., Siuzdak, G., The expanding role of mass spectrometry in metabolite profiling and characterization. Chem. Biochem. 2005, 6, 1941-1951.
24. Rozaklis, T., Ramsay, S. L., Whitfield, P. D., Ranieri, E. et al., Determination of oligosaccharides in Pompe disease by electrospray ionization tandem massspectrometry. Clin. Chem. 2002, 48, 131-139.
25. Meikle, P. J., Fuller, M., Hopwood, J. J., Mass spectrometry in the study of lysosomal storage disorders. Cell Mol. Biol. 2003, 49, 769-677.
26. Young, S. P., Stevens, R. D., An, Y., Chen, Y. T., Millington, D. S., Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry. Anal. Biochem. 2003, 316, 175-180.
27. Ramsay, S. L., Meikle, P. J., Hopwood, J. J., Clements, P. R., Profiling oligosaccharidurias by electrospray tandem mass spectrometry: Quantifying reducing oligosaccharides. Anal. Biochem. 2005, 345, 30-46.
28. Klein, A., Lebreton, A., Lemoine, J., Perini, J. M. et al., Identification of urinary oligosaccharides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin. Chem. 1998, 44, 2422-2428.
29. Ciucanu, I., Kerek, F., A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 1984, 131, 209.
30. Lundblad, A., Oligosaccharides from human urines. Methods Enzymol. 1978, 50, 226-235.
31. Huttunen, J. K., Neuraminic acid-containing oligosaccharides of human urine: Isolation and identification of di-N-acetylneuraminyl-3-galactosyl-N-acetylgalactosamine, 6-2-Nacetylneuraminyl-lactose, 6-2-N-acetylneuraminyl-N-acetyllactosamine and 3-2-N-acetylneuraminyl-lactose. Ann. Med. Exp. Biol. Fenn. 1966, 44, 1-60.
32. Lundblad, A., Svensson, S., Letters: The structure of a urinary difucosyl pentasaccharide, characteristic of secretors with the blood-group A gene. Carbohydr. Res. 1973, 30, 187-189.
33. Parkkinen, J., Finne, J., Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine. Eur. J. Biochem. 1983, 136, 355-361.
34. Durand, P., Gatti, R., Cavalieri, S., Borrone, C. et al., Sialidosis & Mucolipidosis. Helv. Paediatr. Acta 1977, 32, 391-400.
35. Strecker, G., Hondi-Assah, T., Fournet, B., Spik, G. et al., Structure of the three major sialyl-oligosaccharides excreted in the urine of five patients with three distinct inborn diseases: "I cell disease" and two new types of mucolipidosis. Biochim. Biophys. Acta 1976, 444, 349-358.
36. Michalski, J. C., Strecker, G., Fournet, B., Structures of sialyloligosaccharides excreted in the urine of a patient with Mucolipidosis I. FEBS Lett. 1977, 79, 101-104.
37. Van Pelt, J., Kamerling, J. P., Vliegenthart, J. F., Verheijen, F. W., Galjaard, H., Isolation and structural characterization of sialic acid-containing storage material from mucolipidosis I (sialidosis) fibroblasts. Biochim. Biophys. Acta 1988, 965, 36-45.
38. Kuriyama, M., Ariga, T., Ando, S., Suzuki, M. et al., Four positional isomers of sialyloligosaccharides isolated from the urine of a patient with sialidosis. J. Biol. Chem. 1981, 256, 12316-12321.
39. Paschke, E., Kress, H., Morquio disease type B: Activation of GM1-beta-galactosidase by GM1-activator protein. Biochem. Biophys. Res. Commun. 1982, 109, 568-575.
40. Michalski, J. C., Strecker, G., van Halbeek, H., Dorland, L., Vliegenthart, J. F., The structures of six urinary oligosaccharides that are characteristic for a patient with Morquio syndrome type B. Carbohydr. Res. 1982, 100, 351-363.
41. Michalski, J. C., Lemoine, J., Wieruszeski, J. M., Fournet, B. et al., Characterization of a novel type of chain-terminator Gal beta 1-6Gal beta 1-4)GIcNAc in an oligosaccharide related to N-glycosylated protein glycans isolated from GM1 the urine of patients with gangliosidosis. Eur. J. Biochem. 1991, 198, 521-526.
42. Sandhoff, K., Christomanou, H., Biochemistry and genetics of gangliosidoses. Hum. Genet. 1979, 50, 107-143.
43. Ng-Ying-Kin, N. M., Wolfe, L. S., Oligosaccharides accumulating in the liver from a patient with GM2-gangliosidosis variant O (Sandhoff-Jatzkewitz disease). Biochem. Biophys. Res. Commun. 1974, 59, 837-844.
44. Strecker, G., Herlant-Peers, M. C., Fournet, B., Montreuil, J., Structure of seven oligosaccharides excreted in the urine of a patient with Sandhoff's disease (GM2 gangliosidosis-variant O). Eur. J. Biochem. 1977, 81, 165-171.
45. Warner, T. G., de Kremer, R. D., Sjoberg, E. R., Mock, A. K., Characterization and analysis of branched-chain N-acetylglucosaminyl oligosaccharides accumulating in Sandhoff disease tissue. Evidence that biantennary bisected oligosaccharide side chains of glycoproteins are abundant substrates for lysosomes. J. Biol. Chem. 1985, 260, 6194-6199.
46. Ockerman, P. A., A generalized storage disorder resembling Hurler's syndrome. Lancet 1967, 290, 239-241.
47. Berg, T., Riise, H. M. F., Hansen, G. M., Malm, D. et al., Spectrum of mutations in α-mannosidosis. Am. J. Hum. Genet. 1998, 64, 77-88.
48. Norden, N. E., Lundblad, A., Svensson, S., Autio, S., Characterization of two mannose-containing oligosaccharides isolated from the urine of patients with mannosidosis. Biochemistry 1974, 13, 871-874.
49. Van Halbeek, H., Dorland, L., Veldink, G. A., Vliegenthart, J. F. et al., A 500 MHz 1H NMR study of urinary oligosaccharides from patients with mannosidosis. FEBS Lett. 1980, 121, 71-77.
50. Yamashita, K., Tachibana, Y., Mihara, K., Okada, S. et al., Urinary oligosaccharides of mannosidosis. J. Biol. Chem. 1980, 255, 5126-5133.
51. Pollitt, R. J., Jenner, F. A., Merskey. H., Aspartylglycosaminuria. An inborn error of metabolism associated with mental defect. Lancet 1968, 292, 253-255.
52. Maury, C. P., Aspartylglycosaminuria: An inborn error of glycoprotein catabolism. J. Inherit. Metab. Dis. 1982, 5, 192-196.
53. Liu, X., McNally, D. J., Nothaft, H., Szymanski, C. M. et al., Mass spectrometry-based glycomics strategy for exploring N-linked glycosylation in eukaryotes and bacteria. Anal. Chem. 2006, 78, 6081-6087.
54. Lundblad, A., Masson, P. K., Norden, N. E., Structural determination of three glycoasparagines isolated from the urine of a patient with Aspartylglycosaminuria. Eur. J. Biochem. 1976, 67, 209-214.
55. Sugahara, K., Funakoshi, S., Funakoshi, I., Alla, P., Yamashina, I., Characterization of one neutral and two acidic glycoasparagines isolated from the urine of patients with aspartylglycosylaminuria (AGU). J. Biochem. 1976, 80, 195-201.
56. Sugahara, K., Funakoshi, S., Funakoshi, I., Aula, P., Yamashina, I., Characterization of two glycoasparagines isolated from the urine of patients with aspartylglycosylaminuria (AGU). J. Biochem. 1975, 78, 673-678.
57. Irie, F., Murakoshi, H., Suzuki, T., Suzuki, Y. et al., Characterization of four monosialo and a novel disialo Asn N-glycosides from the urine of a patient with aspartylglycosaminuria. Glycoconj. J. 1995, 12, 290-297.
58. Pollitt, R. J., Pretty, K. M., The glycoasparagines in urine of a patient with aspartylglycosaminuria. Biochem. J. 1974, 141, 141-146.
59. Kousseff, B. G., Beratis, N. G., Danesino, C., Hirschhorn, K., Letter: Genetic heterogeneity in fucosidosis. Lancet 1973, 302, 1387-1388.
60. Durand, P., Borrone, C., Della Cella, G., Fucosidosis. J. Pediatr. 1969, 75, 665-743.
61. Patel, V., Watanabe, I., Zeman, W., Deficiency of alpha-L-fucosidase. Science 1972, 176, 426-427.
62. Yamashita, K., Tachibana, Y., Takada, S., Matsuda, I. et al., Urinary glycopeptides of fucosidosis. J. Biol. Chem. 1979, 254, 4820-4827.
63. Strecker, G., Fournet, B., Montreuil, J., Structure of the three major fucosyl-glycoasparagines accumulating in the urine of a patient with fucosidosis. Biochimie 1978, 60, 725-734.
64. Michalski, J. C., Wieruszeski, J. M., Alonso, C., Cache, P. et al., Characterization and 400-MHz 1H-NMR analysis of urinary fucosyl glycoasparagines in fucosidosis. Eur. J. Biochem. 1991, 201, 439-458.
65. Morelle, W., Michalski, J. C., Analysis of protein glycosylation by mass spectrometry. Nat. Protoc. 2007, 2, 1585-1602.
66. Harvey, D. J., Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom. Rev. 1999, 18, 349-450.
67. Morelle, W., Michalski, J. C., Glycomics and mass spectrometry. Curr. Pharm. Des. 2005, 11, 2615-2645.
68. Wada, Y., Azadi, P., Costello, C. E., Dell, A., et al., Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 2007, 17, 411-422.
69. Neufeld, E. F., Muenzer, J., The mucopolysaccharidoses. in: Scriver, S. R., Beaudet, A. L., Sly, W. S., Valle, D. (Eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th Edn., McGraw-Hill, New York 2001, pp. 3421-3452.